Myriad Uranium (CSE: M): U.S. Uranium Exposure With Discovery-Leverage Potential

A micro-cap explorer positioned to benefit from America’s nuclear resurgence.

‍

Myriad Uranium is emerging as one of the most compelling early-stage U.S. uranium stories, advancing its Copper Mountain Project in Wyoming and Red Basin in New Mexico. The company’s maiden drill program has already validated historical grades — returning intercepts 20 – 60 % higher than legacy data — and confirms the geological continuity of near-surface mineralisation.

At a market cap near C$19 million, Myriad offers pure leverage to uranium exploration success and direct exposure to the strategic premium placed on U.S.-sourced uranium. With domestic supply now a national priority, and a tightening global market, the company is well-timed to benefit from renewed investor interest in North American developers.

The next phase of drilling, planned for FY 2026, aims to extend known mineralised zones and test high-grade targets along strike — a campaign that could materially grow the resource base and re-rate the stock if results align with expectations.

‍